CD4 and angioimmunoblastic T-cell lymphoma: This study was carried out in an EBV-seropositive patient who, after chemotherapy and allo-SCT for a CD4+ AITL, suffered from relapse and simultaneous increase of peripheral blood EBV load, most likely associated with the leukemic relapse of the lymphoma.